Strict COVID lockdowns in France improved cardiovascular health

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measurable impact on vascular health. The study compared the impact on the health of people living in a partial vs. a total lockdown during the beginning of COVID-19.

Nationwide total home confinement, lockdown, was the most striking measure taken to prevent the spread of COVID-19 infection. Previous research has demonstrated that total lockdown resulted in a 54% reduction in physical activity. This, together with anxiety, financial stress, and difficulty securing appointments with doctors, might have hurt cardiovascular health. Lockdowns do, however, have some beneficial effects on cardiovascular health. The social distancing guidelines imposed on people around the world resulted in a reduction in air pollution and increased home cooking. People reduced their consumption of fast food and ready-made meals. People had less work-related stress and slept better. Lockdown has been applied heterogeneously by different countries, providing a unique opportunity to compare the impact of different social-distancing measures on cardiovascular health in a real-life experiment with a large population sample.

Researchers here compared the cardiovascular health of people in France, which imposed strict limitations on peoples' movements, including the shutdown of all non-essential production and commercial activities, to that of people in Germany, which adopted much less stringent social-distancing measures.

Researchers here selected 53,043 people in France and Germany and tracked their health during the spring of 2020 when France’s lockdown began. Some 21.1% of French patients tracked during lockdown showed an overall improvement in cardiovascular health, with a reduction in vascular stiffness and body weight despite a concomitant reduction in physical activity. In France, the improvement in vascular age during lockdown corresponded to a reduction in vascular age of more than three years.

The phenomenon was only modestly present in Germany, where lockdown was partial. The reduction in vascular stiffness was significantly steeper in French patients than in Germans. Vascular age reduction during lockdown was steeper in French than in German participants. French participants also showed a slight but greater weight reduction during lockdown than German participants.

Rosa Maria Bruno, Jean Louis Pépin, Jean Philippe Empana, Rui-Yi Yang, Vincent Vercamer, Paul Jouhaud, Pierre Escourrou, Pierre Boutouyrie.
Home monitoring of arterial pulse-wave velocity during COVID-19 total or partial lockdown using connected smart scales.
European Heart Journal - Digital Health, 2022. doi: 10.1093/ehjdh/ztac027

Most Popular Now

AstraZeneca enters license agreement with KYM Bios…

AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targetin...

Pill for skin disease also curbs excessive drinkin…

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an "incredibly promi...

Pfizer's elranatamab receives FDA and EMA filing a…

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the company's Biologics License Application (BLA) ...

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Nanosatellite shows the way to RNA medicine of the…

The RNA molecule is commonly recognized as messenger between DNA and protein, but it can also be folded into intricate molecular machines. An example of a naturally occur...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...

AI conjures proteins that speed up chemical reacti…

For the first time, scientists have used machine learning to create brand-new enzymes, which are proteins that accelerate chemical reactions. This is an important step in...